Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

AM-6545

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
AM-6545
Identifiers
  • 5-(4-[4-cyanobut-1-ynyl]phenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(1,1-dioxo-thiomorpholino)-1H-pyrazole-3-carboxamide
CAS Number
PubChemCID
ChemSpider
ChEBI
CompTox Dashboard(EPA)
ECHA InfoCard100.216.518Edit this at Wikidata
Chemical and physical data
FormulaC26H23Cl2N5O3S
Molar mass556.46 g·mol−1
3D model (JSmol)
  • O=S4(=O)CCN(CC4)NC(=O)c1nn(-c2ccc(Cl)cc2Cl)c(c1C)-c3ccc(C#CCCC#N)cc3
  • InChI=1S/C26H23Cl2N5O3S/c1-18-24(26(34)31-32-13-15-37(35,36)16-14-32)30-33(23-11-10-21(27)17-22(23)28)25(18)20-8-6-19(7-9-20)5-3-2-4-12-29/h6-11,17H,2,4,13-16H2,1H3,(H,31,34) checkY
  • Key:XBHQLFVDGLPBCK-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)

AM-6545 is a drug which acts as a peripherally selectivesilent antagonist for theCB1receptor, and was developed for the treatment ofobesity. Othercannabinoid antagonists such asrimonabant have been marketed for this application, but have subsequently been withdrawn from sale because of centrally mediated side effects such asdepression andnausea. Because AM-6545 does not cross theblood–brain barrier to any significant extent, it does not produce these kinds of side effects, but has still been shown to effectively reduce appetite and food consumption in animal studies.[1][2][3][4]

See also

[edit]

References

[edit]
  1. ^Tam J, Vemuri VK, Liu J, Bátkai S, Mukhopadhyay B, Godlewski G, Osei-Hyiaman D, Ohnuma S, Ambudkar SV, Pickel J, Makriyannis A, Kunos G (August 2010)."Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity".The Journal of Clinical Investigation.120 (8):2953–66.doi:10.1172/JCI42551.PMC 2912197.PMID 20664173.
  2. ^Randall PA, Vemuri VK, Segovia KN, Torres EF, Hosmer S, Nunes EJ, Santerre JL,Makriyannis A, Salamone JD (November 2010)."The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior".Pharmacology Biochemistry and Behavior.97 (1):179–84.doi:10.1016/j.pbb.2010.07.021.PMC 3522179.PMID 20713079.
  3. ^Cluny NL, Vemuri VK, Chambers AP, Limebeer CL, Bedard H, Wood JT, Lutz B, Zimmer A, Parker LA, Makriyannis A, Sharkey KA (October 2010)."A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents".British Journal of Pharmacology.161 (3):629–42.doi:10.1111/j.1476-5381.2010.00908.x.PMC 2990160.PMID 20880401.
  4. ^Järbe TU, LeMay BJ, Vemuri VK, Vadivel SK, Zvonok A, Makriyannis A (August 2011)."Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats".Psychopharmacology.216 (3):355–65.doi:10.1007/s00213-011-2226-3.PMC 3727221.PMID 21369753.
Phytocannabinoids
(comparison)
Cannabibutols
Cannabichromenes
Cannabicyclols
Cannabidiols
Cannabielsoins
Cannabigerols
Cannabiphorols
Cannabinols
Cannabitriols
Cannabivarins
Delta-8-tetrahydrocannabinols
Delta-9-tetrahydrocannabinols
Delta-10-Tetrahydrocannabinols
Miscellaneous cannabinoids
Active metabolites
Endocannabinoids
Synthetic
cannabinoid
receptor
agonists /
neocannabinoids
Classical cannabinoids
(dibenzopyrans)
Non-classical
cannabinoids
Adamantoylindoles
Benzimidazoles
Benzoylindoles
Cyclohexylphenols
Eicosanoids
Indazole-3-
carboxamides
Indole-3-carboxamides
Indole-3-carboxylates
Naphthoylindazoles
Naphthoylindoles
Naphthoylpyrroles
Naphthylmethylindenes
Naphthylmethylindoles
Phenylacetylindoles
Pyrazolecarboxamides
Tetramethylcyclo-
propanoylindazoles
Tetramethylcyclo-
propanoylindoles
Others
AllostericCBRTooltip Cannabinoid receptorligands
Endocannabinoid
enhancers
(inactivation inhibitors)
Anticannabinoids
(antagonists/inverse
agonists/antibodies)
Retrieved from "https://en.wikipedia.org/w/index.php?title=AM-6545&oldid=1268766055"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp